We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.13B
AUM Growth
+$313M
Cap. Flow
-$26.6M
Cap. Flow %
-0.52%
Top 10 Hldgs %
21.35%
Holding
238
New
15
Increased
78
Reduced
108
Closed
15

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$26.7M
2
KIM icon
Kimco Realty
KIM
+$19.3M
3
T icon
AT&T
T
+$8.62M
4
GIS icon
General Mills
GIS
+$8.3M
5
UNH icon
UnitedHealth
UNH
+$7.75M

Top Sells

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$28.7M
2
UAL icon
United Airlines
UAL
+$9.59M
3
MANH icon
Manhattan Associates
MANH
+$7.97M
4
MET icon
MetLife
MET
+$7.62M
5
SYF icon
Synchrony
SYF
+$7.47M

Sector Composition

Rank Sector Weight
1 Financials 22.78%
2 Technology 14.05%
3 Healthcare 13.12%
4 Industrials 12.85%
5 Consumer Discretionary 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBAY icon
176
eBay
EBAY
$47.9B
$421K 0.01%
10,664
-14,400
-57% -$541K
MMP
177
DELISTED
Magellan Midstream Partners, L.P.
MMP
$413K 0.01%
6,450
AZO icon
178
AutoZone
AZO
$49.8B
$407K 0.01%
370
-50
-12% -$52.6K
ED icon
179
Consolidated Edison
ED
$39.6B
$404K 0.01%
4,606
+180
+4% +$15.5K
MNST icon
180
Monster Beverage
MNST
$92.5B
$389K 0.01%
12,192
-400
-3% -$12.1K
SUI icon
181
Sun Communities
SUI
$14.8B
$385K 0.01%
3,000
SYK icon
182
Stryker
SYK
$128B
$368K 0.01%
1,790
NFLX icon
183
Netflix
NFLX
$306B
$367K 0.01%
9,980
+1,680
+20% +$60.6K
GILD icon
184
Gilead Sciences
GILD
$162B
$355K 0.01%
5,260
-5,708
-52% -$376K
PAYX icon
185
Paychex
PAYX
$41.6B
$342K 0.01%
4,156
-146
-3% -$12.3K
NVO
186
Novo Nordisk
NVO
$200B
$327K 0.01%
12,800
-3,606
-22% -$89.1K
TRV icon
187
Travelers Companies
TRV
$79.9B
$311K 0.01%
2,080
+127
+7% +$18.3K
GLW icon
188
Corning
GLW
$137B
$308K 0.01%
9,276
+66
+0.7% +$2.12K
TGT icon
189
Target
TGT
$67.1B
$293K 0.01%
3,387
+213
+7% +$17.2K
PNC icon
190
PNC Financial Services
PNC
$102B
$289K 0.01%
2,108
-364
-15% -$48.1K
BAX icon
191
Baxter International
BAX
$14.3B
$276K 0.01%
+3,376
New +$262K
DOW icon
192
Dow Inc
DOW
$21.3B
$270K 0.01%
+5,482
New +$289K
HUBB icon
193
Hubbell
HUBB
$27B
$267K 0.01%
2,050
BN icon
194
Brookfield
BN
$108B
$263K 0.01%
15,415
HSY icon
195
Hershey
HSY
$36B
$259K 0.01%
1,931
+6
+0.3% +$762
BP icon
196
BP
BP
$108B
$255K 0.01%
+6,225
New +$261K
PGR icon
197
Progressive
PGR
$123B
$253K ﹤0.01%
3,163
LMT icon
198
Lockheed Martin
LMT
$134B
$240K ﹤0.01%
+659
New +$220K
BLK icon
199
Blackrock
BLK
$174B
$235K ﹤0.01%
500
-62
-11% -$28K
RDS.A
200
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$235K ﹤0.01%
3,614
+88
+2% +$5.63K

Similar funds

Douglas Lane & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Douglas Lane & Associates held 238 positions worth $5.13B, up 6.5% from $4.82B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Douglas Lane & Associates's Q2 2019 filing shows 15 new, 78 increased, 108 reduced and 15 closed positions. Its largest new stake was Ingersoll Rand: 210,389 shares worth $7.28M. The largest sale was Verisk Analytics, an estimated $28.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q2 2019 buy was Ingersoll Rand: 210,389 shares worth $7.28M.
  • Douglas Lane & Associates added most to Zimmer Biomet in Q2 2019, an estimated $26.7M increase.
  • Douglas Lane & Associates's biggest Q2 2019 reduction was Verisk Analytics, cutting an estimated $28.7M.
  • Douglas Lane & Associates fully exited Yum China in Q2 2019, selling an estimated $347K.
  • Douglas Lane & Associates's ten largest holdings make up 21% of its $5.13B portfolio in Q2 2019.
  • Douglas Lane & Associates opened 15 new positions and closed 15 in Q2 2019.
  • Douglas Lane & Associates's portfolio value rose 6.5% quarter-over-quarter to $5.13B.

Based on Douglas Lane & Associates's 13F filing for Q2 2019, filed 8 Jul 2019.